0001209191-18-045455.txt : 20180803 0001209191-18-045455.hdr.sgml : 20180803 20180803212859 ACCESSION NUMBER: 0001209191-18-045455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dispersyn Gerrit CENTRAL INDEX KEY: 0001704417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 18993333 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001533040 RXi Pharmaceuticals Corp RXII 0001704417 Dispersyn Gerrit C/O 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 0 1 0 0 Chief Development Officer Common Stock 2018-08-01 4 A 0 16000 0.00 A 16350 D Stock option (right to buy) 1.79 2018-08-01 4 A 0 16000 0.00 A 2028-08-01 Common stock 16000 16000 D Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments. The stock option will vest in four equal annual installments. Caitlin Kontulis, attorney-in-fact 2018-08-03